Morning Movers 04/02: (WG) (THRX) (AVP) (DANG) Higher; (KERX) (AEZS) (AVII) (OPHC) Lower
Tweet Send to a Friend
Get Alerts KERX Hot Sheet
Up)
Trade KERX Now!
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) 66% LOWER; reported today that the Phase 3 "X-PECT" (Xeloda + Perifosine Evaluation in Colorectal cancer Treatment) clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
AEterna Zentaris (Nasdaq: AEZS) 65.3% LOWER; KRX-0401 (perifosine) is in-licensed by Keryx from AeternaZentaris Inc. in the United States, Canada and Mexico.
AVI BioPharma, Inc. (NASDAQ: AVII) 24.6% LOWER; announced that treatment with eteplirsen met the primary efficacy endpoint in a randomized, double-blind, placebo-controlled Phase IIb study in boys with Duchenne muscular dystrophy (DMD). Eteplirsen administered once weekly at 30mg/kg over 24 weeks resulted in a statistically significant (p d 0.002) increase in novel dystrophin (22.5% dystrophin-positive fibers as a percentage of normal) compared to no increase in the placebo group.
Willbros Group, Inc. (NYSE: WG) 24.3% HIGHER; settles litigation related to West Africa Gas Pipeline Co, sees operating loss of $46 million during Q4. Sees Q4 sales $404.9 million, vs. the Street estimate of $388.5 million. Sees FY12 sales of $1.7-$1.9 billion, vs. the analyst estimate of $1.79 billion. Click here to see the full report.
OptimumBank Holdings (Nasdaq: OPHC) 21.9% LOWER; shares opened about 8 percent lower and then dipped below $3.
Theravance, Inc. (Nasdaq: THRX) 16.5% HIGHER; GlaxoSmithKline plc (NYSE: GSK) and Theravance have entered into a stock purchase agreement, under which Theravance will issue, and GSK will acquire, 10,000,000 shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212,887,000.
Avon Products (NYSE: AVP) 14.6% HIGHER; Coty announced a $23.25 per share cash bid for the company.
Sino Clean Energy, Inc. (NASDAQ: SCEI) 12.3% LOWER; reported Q4 EPS of $0.15. Revenue for the quarter came in at $28 million. Sees FY2012 EPS of $1.35-$1.54. Sino Clean Energy, Inc. sees FY2012 revenue of $150-$168 million.
Groupon, Inc. (NASDAQ: GRPN) 11.6% LOWER; revised results for Q4 and FY11 which reduced sales by$14.3 million. The revisions also resulted in an increase to fourth quarter operating expenses that reduced operating income by $30.0 million, net income by $22.6 million, and earnings per share by $0.04. Financial results for prior periods, including as of and for the nine months ended September 30, 2011, were not affected by the revisions. Q1 results were reaffirmed.
YPF (NYSE: YPF) 11.6% LOWER; reports Saturday suggested the Argentine government will take over the company. BofA downgraded the stock from Buy to Neutral this morning.
E Commerce China Dangdang (NYSE: DANG) 11% HIGHER; continuing to push away from its 200-day SMA which was held late Friday. Shares closed just over resistance at $8 last week and the stock has now pushed over the $9 technical level. Shares have already tested this level several times today.
Towerstream (Nasdaq: TWER) 10.3% HIGHER; reports that it has signed a Wi-Fi agreement with a national wireless carrier utilizing its current and future rooftop assets.
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) 10.1% HIGHER; announced today the successful launch by NASA of an Oriole rocket system produced by its Rocket Support Services (RSS) business unit located in Glen Burnie, Maryland.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
AEterna Zentaris (Nasdaq: AEZS) 65.3% LOWER; KRX-0401 (perifosine) is in-licensed by Keryx from AeternaZentaris Inc. in the United States, Canada and Mexico.
AVI BioPharma, Inc. (NASDAQ: AVII) 24.6% LOWER; announced that treatment with eteplirsen met the primary efficacy endpoint in a randomized, double-blind, placebo-controlled Phase IIb study in boys with Duchenne muscular dystrophy (DMD). Eteplirsen administered once weekly at 30mg/kg over 24 weeks resulted in a statistically significant (p d 0.002) increase in novel dystrophin (22.5% dystrophin-positive fibers as a percentage of normal) compared to no increase in the placebo group.
Willbros Group, Inc. (NYSE: WG) 24.3% HIGHER; settles litigation related to West Africa Gas Pipeline Co, sees operating loss of $46 million during Q4. Sees Q4 sales $404.9 million, vs. the Street estimate of $388.5 million. Sees FY12 sales of $1.7-$1.9 billion, vs. the analyst estimate of $1.79 billion. Click here to see the full report.
OptimumBank Holdings (Nasdaq: OPHC) 21.9% LOWER; shares opened about 8 percent lower and then dipped below $3.
Theravance, Inc. (Nasdaq: THRX) 16.5% HIGHER; GlaxoSmithKline plc (NYSE: GSK) and Theravance have entered into a stock purchase agreement, under which Theravance will issue, and GSK will acquire, 10,000,000 shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212,887,000.
Avon Products (NYSE: AVP) 14.6% HIGHER; Coty announced a $23.25 per share cash bid for the company.
Sino Clean Energy, Inc. (NASDAQ: SCEI) 12.3% LOWER; reported Q4 EPS of $0.15. Revenue for the quarter came in at $28 million. Sees FY2012 EPS of $1.35-$1.54. Sino Clean Energy, Inc. sees FY2012 revenue of $150-$168 million.
Groupon, Inc. (NASDAQ: GRPN) 11.6% LOWER; revised results for Q4 and FY11 which reduced sales by$14.3 million. The revisions also resulted in an increase to fourth quarter operating expenses that reduced operating income by $30.0 million, net income by $22.6 million, and earnings per share by $0.04. Financial results for prior periods, including as of and for the nine months ended September 30, 2011, were not affected by the revisions. Q1 results were reaffirmed.
YPF (NYSE: YPF) 11.6% LOWER; reports Saturday suggested the Argentine government will take over the company. BofA downgraded the stock from Buy to Neutral this morning.
E Commerce China Dangdang (NYSE: DANG) 11% HIGHER; continuing to push away from its 200-day SMA which was held late Friday. Shares closed just over resistance at $8 last week and the stock has now pushed over the $9 technical level. Shares have already tested this level several times today.
Towerstream (Nasdaq: TWER) 10.3% HIGHER; reports that it has signed a Wi-Fi agreement with a national wireless carrier utilizing its current and future rooftop assets.
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) 10.1% HIGHER; announced today the successful launch by NASA of an Oriole rocket system produced by its Rocket Support Services (RSS) business unit located in Glen Burnie, Maryland.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Bank of America, Morning Movers, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
